• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促红细胞生成素、5-氟尿嘧啶和 SN-38 对 DLD-1 细胞生长的影响。

Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells.

机构信息

Department of Pharmacodynamics, Medical University of Bialystok, Mickiewicza 2C, 15-222 Białystok, Poland.

出版信息

Pharmacol Rep. 2010 Sep-Oct;62(5):926-37. doi: 10.1016/s1734-1140(10)70353-4.

DOI:10.1016/s1734-1140(10)70353-4
PMID:21098876
Abstract

Supplementation of recombinant human erythropoietin (rHuEpo) is one of the methods for the treatment of anemia. The influence of rHuEpo on proliferation or clonogenic growth of cancer cells is not clear and some of the published results are conflicting. The aim of this work was to study the effect of rHuEpo on colon cancer cells when given alone or in combination with cytostatics. Human colon adenocarcinoma cells (DLD-1) were cultured in medium with rHuEpo, 5-fluorouracil (5-FU) and an active metabolite of irinotecan (SN-38). Cell viability was determined using a hematocytometer and 0.4% (w/v) trypan blue dye. Cell proliferation was measured by the MTT assay. Expression of EpoR, Bax, Bcl-2 and Akt1 protein was assessed by Western blot. The results of this study indicate a dose-dependent inhibitory effect of rHuEpo on DLD-1 cell growth and proliferation. Moreover, the combined treatment of rHuEpo and cytotoxic agents such as 5-FU and SN-38 increases the antitumor action, which is indicated by decreases in proliferation in the MTT test, cell numbers and DNA synthesis. We found a significant increase in EpoR, Bcl-2 and Akt1 protein expression in all cells grown in medium containing 3 IU of rHuEpo. We observed that EpoR is constitutively expressed in DLD-1 cells. Our results indicate that rHuEpo acts via EpoR to directly inhibit DLD-1 cell growth and indirectly modulate the cytostatics effects of 5-FU and SN-38.

摘要

重组人促红细胞生成素(rHuEpo)的补充是治疗贫血的方法之一。rHuEpo 对癌细胞的增殖或集落形成生长的影响尚不清楚,一些已发表的结果相互矛盾。本工作旨在研究 rHuEpo 单独或与细胞毒药物联合应用对结肠癌细胞的影响。人结肠腺癌细胞(DLD-1)在含有 rHuEpo、5-氟尿嘧啶(5-FU)和伊立替康活性代谢物(SN-38)的培养基中培养。使用血细胞计数器和 0.4%(w/v)台盼蓝染料测定细胞活力。通过 MTT 测定法测量细胞增殖。通过 Western blot 评估 EpoR、Bax、Bcl-2 和 Akt1 蛋白的表达。本研究的结果表明 rHuEpo 对 DLD-1 细胞生长和增殖具有剂量依赖性抑制作用。此外,rHuEpo 与细胞毒药物如 5-FU 和 SN-38 的联合治疗增加了抗肿瘤作用,这表现在 MTT 试验、细胞数量和 DNA 合成的增殖减少。我们发现,在含有 3IU rHuEpo 的培养基中生长的所有细胞中,EpoR、Bcl-2 和 Akt1 蛋白的表达均显著增加。我们观察到 EpoR 在 DLD-1 细胞中持续表达。我们的结果表明,rHuEpo 通过 EpoR 直接抑制 DLD-1 细胞生长,并间接调节 5-FU 和 SN-38 的细胞毒作用。

相似文献

1
Effect of erythropoietin, 5-fluorouracil and SN-38 on the growth of DLD-1 cells.促红细胞生成素、5-氟尿嘧啶和 SN-38 对 DLD-1 细胞生长的影响。
Pharmacol Rep. 2010 Sep-Oct;62(5):926-37. doi: 10.1016/s1734-1140(10)70353-4.
2
Erythropoietin Enhances the Cytotoxic Effect of Hydrogen Peroxide on Colon Cancer Cells.促红细胞生成素增强过氧化氢对结肠癌细胞的细胞毒性作用。
Curr Pharm Biotechnol. 2017;18(2):127-137. doi: 10.2174/1389201018666161116092907.
3
Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models.在促红细胞生成素受体阳性乳腺癌模型中,重组促红细胞生成素不会刺激肿瘤生长。
Mol Cancer Ther. 2006 Feb;5(2):347-55. doi: 10.1158/1535-7163.MCT-05-0203.
4
Recombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft models.重组人促红细胞生成素α靶向肿瘤内血管,改善人异种移植模型中的化疗效果。
Cancer Res. 2005 Aug 15;65(16):7186-93. doi: 10.1158/0008-5472.CAN-04-2498.
5
Recombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexed.重组促红细胞生成素对间皮瘤细胞的增殖有不同影响,但对顺铂和培美曲塞的敏感性无影响。
Cancer Chemother Pharmacol. 2008 Apr;61(5):893-901. doi: 10.1007/s00280-007-0608-3. Epub 2007 Oct 6.
6
Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.促红细胞生成蛋白在顺铂诱导的急性肾损伤模型中的抗凋亡特性
Am J Physiol Renal Physiol. 2008 Jun;294(6):F1354-65. doi: 10.1152/ajprenal.00131.2008. Epub 2008 Apr 2.
7
Sequential treatment with SN-38 followed by 5-fluorouracil shows synergistic cytotoxic activity in small cell lung cancer cells.先用SN - 38治疗,随后用5 - 氟尿嘧啶进行序贯治疗,在小细胞肺癌细胞中显示出协同细胞毒性活性。
Oncol Rep. 2008 Apr;19(4):945-51.
8
Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.同时使用促红细胞生成素和 LFM-A13 作为结直肠癌的一种新治疗方法。
Br J Pharmacol. 2018 Mar;175(5):743-762. doi: 10.1111/bph.14099. Epub 2018 Jan 25.
9
Erythropoietin improves insulin resistance via the regulation of its receptor-mediated signaling pathways in 3T3L1 adipocytes.促红细胞生成素通过调节 3T3L1 脂肪细胞中其受体介导的信号通路改善胰岛素抵抗。
Mol Cell Endocrinol. 2013 Mar 10;367(1-2):116-23. doi: 10.1016/j.mce.2012.12.027. Epub 2013 Jan 11.
10
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.促红细胞生成素通过增加促红细胞生成素受体(EpoR)以及刺激DLD-1和Ht-29异种移植瘤中的血管生成来加速肿瘤生长。
Mol Cell Biochem. 2016 Oct;421(1-2):1-18. doi: 10.1007/s11010-016-2779-x. Epub 2016 Aug 20.

引用本文的文献

1
ONCOBREAST-TEST Is a Quick Diagnostic, Prognostic and Predictive Method of Response to Systemic Treatment.ONCOBREAST-TEST是一种针对全身治疗反应的快速诊断、预后评估和预测方法。
Cancers (Basel). 2023 Dec 26;16(1):120. doi: 10.3390/cancers16010120.
2
Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer.促红细胞生成素增强 LFM-A13 在细胞和结直肠癌小鼠模型中的促凋亡活性。
Int J Mol Sci. 2018 Apr 23;19(4):1262. doi: 10.3390/ijms19041262.
3
Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.
同时使用促红细胞生成素和 LFM-A13 作为结直肠癌的一种新治疗方法。
Br J Pharmacol. 2018 Mar;175(5):743-762. doi: 10.1111/bph.14099. Epub 2018 Jan 25.
4
Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.促红细胞生成素通过增加促红细胞生成素受体(EpoR)以及刺激DLD-1和Ht-29异种移植瘤中的血管生成来加速肿瘤生长。
Mol Cell Biochem. 2016 Oct;421(1-2):1-18. doi: 10.1007/s11010-016-2779-x. Epub 2016 Aug 20.